Werner Krammer: How Escitalopram Can Support Motor Recovery Post Cortical Sensori-Motor Stroke
Werner Krammer, Senior Physician at Zihlschlacht Rehabilitation Clinic, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
‘‘I am excited to share our latest research from the Support Center for Advanced Neuroimaging (SCAN) at the Inselspital, University Hospital Bern.
In our recent longitudinal study, we explored how Escitalopram can support motor recovery following cortical sensori-motor stroke.
Our findings suggest that the medication promotes significant recovery from hand paresis, offering a promising avenue for enhancing post-stroke rehabilitation.
A huge thank you to my colleagues and the entire team for their dedication to advancing neuro-rehabilitation.”
Title: Escitalopram promotes recovery from hand paresis in cortical sensori-motor stroke: a randomized, double-blind, placebo-controlled longitudinal study
Authors: Vanessa Vallesi, Werner Krammer, Andrea Federspiel, John H. Missimer, Manuela Pastore-Wapp, Georg Kägi, Roland Wiest, Bruno J. Weder
Read the Full Article on Journal of NeuroEngineering and Rehabilitation
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 16, 2026, 15:23Ifeanyichukwu Ifechidere – Argatroban: Its ‘Rescue Mission’ in Heparin-Induced Thrombocytopenia
-
Apr 16, 2026, 14:58When Early Diagnosis Is the First Step in Hemophilia A Care – WFH
-
Apr 16, 2026, 14:05Saleh Shamse Basha: When Platelet Counts Mislead, The PLT-F Becomes Critical
-
Apr 16, 2026, 13:44Maha Othman: Celebrating National Medical Laboratory Week in Canada
-
Apr 16, 2026, 13:42Megan Adediran: How Much of What You Know About Hemophilia Is True?
-
Apr 16, 2026, 13:35Priya Singh: How to Write the Discussion of a Research Paper
-
Apr 16, 2026, 13:14Veronica Sanchez: Blood Pressure Categories for Individuals Who Are Pregnant
-
Apr 16, 2026, 13:07Abdul Mannan: Acute Anaphylactic Reaction During Blood Transfusion
-
Apr 16, 2026, 09:41Wolfgang Miesbach: Adeno-Associated Virus Neutralizing Antibodies and Their Clinical Impact on Gene Therapy